Model relies only on age, smoking duration, and pack-years
Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy
Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC
Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping
AUROC estimate of four-marker protein panel plus PLCO<sub>m2012</sub> was 0.88 for risk prediction of lung cancer death
Yet, variation in uptake seen by geography, race, smoking history, and age